GPATCH2
G patch domain-containing protein 2
Also known as: CT110, FLJ10252, GPATC2, GPTC2_HUMAN, Pfa1, PPP1R30
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NW75
- Gene
- GPATCH2
- Ensembl
- ENSG00000092978
- Chromosome
- 1
- Canonical length
- 528 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
The gene encodes a nuclear factor that may play a role in spermatogenesis and in tumor growth during breast cancer. The encoded protein contains a G-patch domain with an RNA binding motif. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
528 residues, UniProt reviewed canonical sequence.
>Q9NW75|GPATCH2
1 MFGAAGRQPI GAPAAGNSWH FSRTMEELVH DLVSALEESS EQARGGFAET GDHSRSISCP
61 LKRQARKRRG RKRRSYNVHH PWETGHCLSE GSDSSLEEPS KDYRENHNNN KKDHSDSDDQ
121 MLVAKRRPSS NLNNNVRGKR PLWHESDFAV DNVGNRTLRR RRKVKRMAVD LPQDISNKRT
181 MTQPPEGCRD QDMDSDRAYQ YQEFTKNKVK KRKLKIIRQG PKIQDEGVVL ESEETNQTNK
241 DKMECEEQKV SDELMSESDS SSLSSTDAGL FTNDEGRQGD DEQSDWFYEK ESGGACGITG
301 VVPWWEKEDP TELDKNVPDP VFESILTGSF PLMSHPSRRG FQARLSRLHG MSSKNIKKSG
361 GTPTSMVPIP GPVGNKRMVH FSPDSHHHDH WFSPGARTEH DQHQLLRDNR AERGHKKNCS
421 VRTASRQTSM HLGSLCTGDI KRRRKAAPLP GPTTAGFVGE NAQPILENNI GNRMLQNMGW
481 TPGSGLGRDG KGISEPIQAM QRPKGLGLGF PLPKSTSATT TPNAGKSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPATCH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 6.7 nTPM
Expression across tissuesHPA
Tissue
- breast: 6.7 nTPM
- parathyroid gland: 6.5 nTPM
- prostate: 6.5 nTPM
- skeletal muscle: 6.2 nTPM
- thyroid gland: 6.2 nTPM
- endometrium: 6.1 nTPM
Single-cell type
- choroid plexus epithelial cells: 319 nCPM
- cardiomyocytes: 255 nCPM
- gonadotrophs: 236 nCPM
- pituicytes/fscs: 232 nCPM
- prostatic glandular cells: 213 nCPM
- lactotrophs: 185 nCPM
Immune cell
- plasmacytoid DC: 5 nTPM
- basophil: 4.1 nTPM
- myeloid DC: 3.4 nTPM
- classical monocyte: 3.1 nTPM
- memory CD4 T-cell: 3 nTPM
- non-classical monocyte: 2.9 nTPM
Brain region
- choroid plexus: 18 nTPM
- hypothalamus: 15 nTPM
- cerebral cortex: 14 nTPM
- hippocampal formation: 13 nTPM
- basal ganglia: 13 nTPM
- white matter: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPATCH2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPATCH2 as an antibody target. Whether an autoantibody or antibody against GPATCH2 could matter depends on whether native GPATCH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPATCH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GPATCH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...